Global Humira Biosimilar Supply, Demand and Key Producers, 2023-2029
The global Humira Biosimilar market size is expected to reach $ 955.4 million by 2029, rising at a market growth of 12.0% CAGR during the forecast period (2023-2029).
The introduction of Humira biosimilars is expected to increase competition in the market, leading to lower prices and improved access to treatment for patients. The availability of biosimilars provides an alternative option for healthcare providers and payers to choose from, potentially reducing the overall healthcare expenditure associated with biologic treatments.
Humira is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
This report studies the global Humira Biosimilar production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Humira Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Humira Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Humira Biosimilar total production and demand, 2018-2029, (K Units)
Global Humira Biosimilar total production value, 2018-2029, (USD Million)
Global Humira Biosimilar production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Humira Biosimilar consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Humira Biosimilar domestic production, consumption, key domestic manufacturers and share
Global Humira Biosimilar production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Humira Biosimilar production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Humira Biosimilar production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Humira Biosimilar market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cadila Healthcare, Torrent Pharmaceuticals, Amgen, Boehringer Ingelheim, Novartis, Samsung Bioepis, Viatris, Pfizer and Fresenius Kabi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Humira Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Humira Biosimilar Market, By Region:
1. How big is the global Humira Biosimilar market?
2. What is the demand of the global Humira Biosimilar market?
3. What is the year over year growth of the global Humira Biosimilar market?
4. What is the production and production value of the global Humira Biosimilar market?
5. Who are the key producers in the global Humira Biosimilar market?
6. What are the growth factors driving the market demand?
The introduction of Humira biosimilars is expected to increase competition in the market, leading to lower prices and improved access to treatment for patients. The availability of biosimilars provides an alternative option for healthcare providers and payers to choose from, potentially reducing the overall healthcare expenditure associated with biologic treatments.
Humira is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
This report studies the global Humira Biosimilar production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Humira Biosimilar, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Humira Biosimilar that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Humira Biosimilar total production and demand, 2018-2029, (K Units)
Global Humira Biosimilar total production value, 2018-2029, (USD Million)
Global Humira Biosimilar production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Humira Biosimilar consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Humira Biosimilar domestic production, consumption, key domestic manufacturers and share
Global Humira Biosimilar production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Humira Biosimilar production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Humira Biosimilar production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Humira Biosimilar market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cadila Healthcare, Torrent Pharmaceuticals, Amgen, Boehringer Ingelheim, Novartis, Samsung Bioepis, Viatris, Pfizer and Fresenius Kabi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Humira Biosimilar market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Humira Biosimilar Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Syringe
- Pen
- Ankylosing Spondylitis
- Rheumatoid Arthritis
- Crohn’s Disease
- Other
- Cadila Healthcare
- Torrent Pharmaceuticals
- Amgen
- Boehringer Ingelheim
- Novartis
- Samsung Bioepis
- Viatris
- Pfizer
- Fresenius Kabi
- Coherus
1. How big is the global Humira Biosimilar market?
2. What is the demand of the global Humira Biosimilar market?
3. What is the year over year growth of the global Humira Biosimilar market?
4. What is the production and production value of the global Humira Biosimilar market?
5. Who are the key producers in the global Humira Biosimilar market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Humira Biosimilar Introduction
1.2 World Humira Biosimilar Supply & Forecast
1.2.1 World Humira Biosimilar Production Value (2018 & 2022 & 2029)
1.2.2 World Humira Biosimilar Production (2018-2029)
1.2.3 World Humira Biosimilar Pricing Trends (2018-2029)
1.3 World Humira Biosimilar Production by Region (Based on Production Site)
1.3.1 World Humira Biosimilar Production Value by Region (2018-2029)
1.3.2 World Humira Biosimilar Production by Region (2018-2029)
1.3.3 World Humira Biosimilar Average Price by Region (2018-2029)
1.3.4 North America Humira Biosimilar Production (2018-2029)
1.3.5 Europe Humira Biosimilar Production (2018-2029)
1.3.6 China Humira Biosimilar Production (2018-2029)
1.3.7 Japan Humira Biosimilar Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Humira Biosimilar Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Humira Biosimilar Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Humira Biosimilar Demand (2018-2029)
2.2 World Humira Biosimilar Consumption by Region
2.2.1 World Humira Biosimilar Consumption by Region (2018-2023)
2.2.2 World Humira Biosimilar Consumption Forecast by Region (2024-2029)
2.3 United States Humira Biosimilar Consumption (2018-2029)
2.4 China Humira Biosimilar Consumption (2018-2029)
2.5 Europe Humira Biosimilar Consumption (2018-2029)
2.6 Japan Humira Biosimilar Consumption (2018-2029)
2.7 South Korea Humira Biosimilar Consumption (2018-2029)
2.8 ASEAN Humira Biosimilar Consumption (2018-2029)
2.9 India Humira Biosimilar Consumption (2018-2029)
3 WORLD HUMIRA BIOSIMILAR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Humira Biosimilar Production Value by Manufacturer (2018-2023)
3.2 World Humira Biosimilar Production by Manufacturer (2018-2023)
3.3 World Humira Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Humira Biosimilar Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Humira Biosimilar Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Humira Biosimilar in 2022
3.5.3 Global Concentration Ratios (CR8) for Humira Biosimilar in 2022
3.6 Humira Biosimilar Market: Overall Company Footprint Analysis
3.6.1 Humira Biosimilar Market: Region Footprint
3.6.2 Humira Biosimilar Market: Company Product Type Footprint
3.6.3 Humira Biosimilar Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Humira Biosimilar Production Value Comparison
4.1.1 United States VS China: Humira Biosimilar Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Humira Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Humira Biosimilar Production Comparison
4.2.1 United States VS China: Humira Biosimilar Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Humira Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Humira Biosimilar Consumption Comparison
4.3.1 United States VS China: Humira Biosimilar Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Humira Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Humira Biosimilar Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Humira Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Humira Biosimilar Production Value (2018-2023)
4.4.3 United States Based Manufacturers Humira Biosimilar Production (2018-2023)
4.5 China Based Humira Biosimilar Manufacturers and Market Share
4.5.1 China Based Humira Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Humira Biosimilar Production Value (2018-2023)
4.5.3 China Based Manufacturers Humira Biosimilar Production (2018-2023)
4.6 Rest of World Based Humira Biosimilar Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Humira Biosimilar Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Humira Biosimilar Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Humira Biosimilar Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Humira Biosimilar Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Syringe
5.2.2 Pen
5.3 Market Segment by Type
5.3.1 World Humira Biosimilar Production by Type (2018-2029)
5.3.2 World Humira Biosimilar Production Value by Type (2018-2029)
5.3.3 World Humira Biosimilar Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Humira Biosimilar Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Ankylosing Spondylitis
6.2.2 Rheumatoid Arthritis
6.2.3 Crohn’s Disease
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Humira Biosimilar Production by Application (2018-2029)
6.3.2 World Humira Biosimilar Production Value by Application (2018-2029)
6.3.3 World Humira Biosimilar Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Cadila Healthcare
7.1.1 Cadila Healthcare Details
7.1.2 Cadila Healthcare Major Business
7.1.3 Cadila Healthcare Humira Biosimilar Product and Services
7.1.4 Cadila Healthcare Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Cadila Healthcare Recent Developments/Updates
7.1.6 Cadila Healthcare Competitive Strengths & Weaknesses
7.2 Torrent Pharmaceuticals
7.2.1 Torrent Pharmaceuticals Details
7.2.2 Torrent Pharmaceuticals Major Business
7.2.3 Torrent Pharmaceuticals Humira Biosimilar Product and Services
7.2.4 Torrent Pharmaceuticals Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Torrent Pharmaceuticals Recent Developments/Updates
7.2.6 Torrent Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Amgen
7.3.1 Amgen Details
7.3.2 Amgen Major Business
7.3.3 Amgen Humira Biosimilar Product and Services
7.3.4 Amgen Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Amgen Recent Developments/Updates
7.3.6 Amgen Competitive Strengths & Weaknesses
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Details
7.4.2 Boehringer Ingelheim Major Business
7.4.3 Boehringer Ingelheim Humira Biosimilar Product and Services
7.4.4 Boehringer Ingelheim Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Boehringer Ingelheim Recent Developments/Updates
7.4.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis Humira Biosimilar Product and Services
7.5.4 Novartis Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Samsung Bioepis
7.6.1 Samsung Bioepis Details
7.6.2 Samsung Bioepis Major Business
7.6.3 Samsung Bioepis Humira Biosimilar Product and Services
7.6.4 Samsung Bioepis Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Samsung Bioepis Recent Developments/Updates
7.6.6 Samsung Bioepis Competitive Strengths & Weaknesses
7.7 Viatris
7.7.1 Viatris Details
7.7.2 Viatris Major Business
7.7.3 Viatris Humira Biosimilar Product and Services
7.7.4 Viatris Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Viatris Recent Developments/Updates
7.7.6 Viatris Competitive Strengths & Weaknesses
7.8 Pfizer
7.8.1 Pfizer Details
7.8.2 Pfizer Major Business
7.8.3 Pfizer Humira Biosimilar Product and Services
7.8.4 Pfizer Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Pfizer Recent Developments/Updates
7.8.6 Pfizer Competitive Strengths & Weaknesses
7.9 Fresenius Kabi
7.9.1 Fresenius Kabi Details
7.9.2 Fresenius Kabi Major Business
7.9.3 Fresenius Kabi Humira Biosimilar Product and Services
7.9.4 Fresenius Kabi Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Fresenius Kabi Recent Developments/Updates
7.9.6 Fresenius Kabi Competitive Strengths & Weaknesses
7.10 Coherus
7.10.1 Coherus Details
7.10.2 Coherus Major Business
7.10.3 Coherus Humira Biosimilar Product and Services
7.10.4 Coherus Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Coherus Recent Developments/Updates
7.10.6 Coherus Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Humira Biosimilar Industry Chain
8.2 Humira Biosimilar Upstream Analysis
8.2.1 Humira Biosimilar Core Raw Materials
8.2.2 Main Manufacturers of Humira Biosimilar Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Humira Biosimilar Production Mode
8.6 Humira Biosimilar Procurement Model
8.7 Humira Biosimilar Industry Sales Model and Sales Channels
8.7.1 Humira Biosimilar Sales Model
8.7.2 Humira Biosimilar Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Humira Biosimilar Introduction
1.2 World Humira Biosimilar Supply & Forecast
1.2.1 World Humira Biosimilar Production Value (2018 & 2022 & 2029)
1.2.2 World Humira Biosimilar Production (2018-2029)
1.2.3 World Humira Biosimilar Pricing Trends (2018-2029)
1.3 World Humira Biosimilar Production by Region (Based on Production Site)
1.3.1 World Humira Biosimilar Production Value by Region (2018-2029)
1.3.2 World Humira Biosimilar Production by Region (2018-2029)
1.3.3 World Humira Biosimilar Average Price by Region (2018-2029)
1.3.4 North America Humira Biosimilar Production (2018-2029)
1.3.5 Europe Humira Biosimilar Production (2018-2029)
1.3.6 China Humira Biosimilar Production (2018-2029)
1.3.7 Japan Humira Biosimilar Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Humira Biosimilar Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Humira Biosimilar Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Humira Biosimilar Demand (2018-2029)
2.2 World Humira Biosimilar Consumption by Region
2.2.1 World Humira Biosimilar Consumption by Region (2018-2023)
2.2.2 World Humira Biosimilar Consumption Forecast by Region (2024-2029)
2.3 United States Humira Biosimilar Consumption (2018-2029)
2.4 China Humira Biosimilar Consumption (2018-2029)
2.5 Europe Humira Biosimilar Consumption (2018-2029)
2.6 Japan Humira Biosimilar Consumption (2018-2029)
2.7 South Korea Humira Biosimilar Consumption (2018-2029)
2.8 ASEAN Humira Biosimilar Consumption (2018-2029)
2.9 India Humira Biosimilar Consumption (2018-2029)
3 WORLD HUMIRA BIOSIMILAR MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Humira Biosimilar Production Value by Manufacturer (2018-2023)
3.2 World Humira Biosimilar Production by Manufacturer (2018-2023)
3.3 World Humira Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Humira Biosimilar Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Humira Biosimilar Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Humira Biosimilar in 2022
3.5.3 Global Concentration Ratios (CR8) for Humira Biosimilar in 2022
3.6 Humira Biosimilar Market: Overall Company Footprint Analysis
3.6.1 Humira Biosimilar Market: Region Footprint
3.6.2 Humira Biosimilar Market: Company Product Type Footprint
3.6.3 Humira Biosimilar Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Humira Biosimilar Production Value Comparison
4.1.1 United States VS China: Humira Biosimilar Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Humira Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Humira Biosimilar Production Comparison
4.2.1 United States VS China: Humira Biosimilar Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Humira Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Humira Biosimilar Consumption Comparison
4.3.1 United States VS China: Humira Biosimilar Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Humira Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Humira Biosimilar Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Humira Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Humira Biosimilar Production Value (2018-2023)
4.4.3 United States Based Manufacturers Humira Biosimilar Production (2018-2023)
4.5 China Based Humira Biosimilar Manufacturers and Market Share
4.5.1 China Based Humira Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Humira Biosimilar Production Value (2018-2023)
4.5.3 China Based Manufacturers Humira Biosimilar Production (2018-2023)
4.6 Rest of World Based Humira Biosimilar Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Humira Biosimilar Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Humira Biosimilar Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Humira Biosimilar Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Humira Biosimilar Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Syringe
5.2.2 Pen
5.3 Market Segment by Type
5.3.1 World Humira Biosimilar Production by Type (2018-2029)
5.3.2 World Humira Biosimilar Production Value by Type (2018-2029)
5.3.3 World Humira Biosimilar Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Humira Biosimilar Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Ankylosing Spondylitis
6.2.2 Rheumatoid Arthritis
6.2.3 Crohn’s Disease
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Humira Biosimilar Production by Application (2018-2029)
6.3.2 World Humira Biosimilar Production Value by Application (2018-2029)
6.3.3 World Humira Biosimilar Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Cadila Healthcare
7.1.1 Cadila Healthcare Details
7.1.2 Cadila Healthcare Major Business
7.1.3 Cadila Healthcare Humira Biosimilar Product and Services
7.1.4 Cadila Healthcare Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Cadila Healthcare Recent Developments/Updates
7.1.6 Cadila Healthcare Competitive Strengths & Weaknesses
7.2 Torrent Pharmaceuticals
7.2.1 Torrent Pharmaceuticals Details
7.2.2 Torrent Pharmaceuticals Major Business
7.2.3 Torrent Pharmaceuticals Humira Biosimilar Product and Services
7.2.4 Torrent Pharmaceuticals Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Torrent Pharmaceuticals Recent Developments/Updates
7.2.6 Torrent Pharmaceuticals Competitive Strengths & Weaknesses
7.3 Amgen
7.3.1 Amgen Details
7.3.2 Amgen Major Business
7.3.3 Amgen Humira Biosimilar Product and Services
7.3.4 Amgen Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Amgen Recent Developments/Updates
7.3.6 Amgen Competitive Strengths & Weaknesses
7.4 Boehringer Ingelheim
7.4.1 Boehringer Ingelheim Details
7.4.2 Boehringer Ingelheim Major Business
7.4.3 Boehringer Ingelheim Humira Biosimilar Product and Services
7.4.4 Boehringer Ingelheim Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Boehringer Ingelheim Recent Developments/Updates
7.4.6 Boehringer Ingelheim Competitive Strengths & Weaknesses
7.5 Novartis
7.5.1 Novartis Details
7.5.2 Novartis Major Business
7.5.3 Novartis Humira Biosimilar Product and Services
7.5.4 Novartis Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Novartis Recent Developments/Updates
7.5.6 Novartis Competitive Strengths & Weaknesses
7.6 Samsung Bioepis
7.6.1 Samsung Bioepis Details
7.6.2 Samsung Bioepis Major Business
7.6.3 Samsung Bioepis Humira Biosimilar Product and Services
7.6.4 Samsung Bioepis Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Samsung Bioepis Recent Developments/Updates
7.6.6 Samsung Bioepis Competitive Strengths & Weaknesses
7.7 Viatris
7.7.1 Viatris Details
7.7.2 Viatris Major Business
7.7.3 Viatris Humira Biosimilar Product and Services
7.7.4 Viatris Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Viatris Recent Developments/Updates
7.7.6 Viatris Competitive Strengths & Weaknesses
7.8 Pfizer
7.8.1 Pfizer Details
7.8.2 Pfizer Major Business
7.8.3 Pfizer Humira Biosimilar Product and Services
7.8.4 Pfizer Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Pfizer Recent Developments/Updates
7.8.6 Pfizer Competitive Strengths & Weaknesses
7.9 Fresenius Kabi
7.9.1 Fresenius Kabi Details
7.9.2 Fresenius Kabi Major Business
7.9.3 Fresenius Kabi Humira Biosimilar Product and Services
7.9.4 Fresenius Kabi Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Fresenius Kabi Recent Developments/Updates
7.9.6 Fresenius Kabi Competitive Strengths & Weaknesses
7.10 Coherus
7.10.1 Coherus Details
7.10.2 Coherus Major Business
7.10.3 Coherus Humira Biosimilar Product and Services
7.10.4 Coherus Humira Biosimilar Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Coherus Recent Developments/Updates
7.10.6 Coherus Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Humira Biosimilar Industry Chain
8.2 Humira Biosimilar Upstream Analysis
8.2.1 Humira Biosimilar Core Raw Materials
8.2.2 Main Manufacturers of Humira Biosimilar Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Humira Biosimilar Production Mode
8.6 Humira Biosimilar Procurement Model
8.7 Humira Biosimilar Industry Sales Model and Sales Channels
8.7.1 Humira Biosimilar Sales Model
8.7.2 Humira Biosimilar Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Humira Biosimilar Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Humira Biosimilar Production Value by Region (2018-2023) & (USD Million)
Table 3. World Humira Biosimilar Production Value by Region (2024-2029) & (USD Million)
Table 4. World Humira Biosimilar Production Value Market Share by Region (2018-2023)
Table 5. World Humira Biosimilar Production Value Market Share by Region (2024-2029)
Table 6. World Humira Biosimilar Production by Region (2018-2023) & (K Units)
Table 7. World Humira Biosimilar Production by Region (2024-2029) & (K Units)
Table 8. World Humira Biosimilar Production Market Share by Region (2018-2023)
Table 9. World Humira Biosimilar Production Market Share by Region (2024-2029)
Table 10. World Humira Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Humira Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Humira Biosimilar Major Market Trends
Table 13. World Humira Biosimilar Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Humira Biosimilar Consumption by Region (2018-2023) & (K Units)
Table 15. World Humira Biosimilar Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Humira Biosimilar Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Humira Biosimilar Producers in 2022
Table 18. World Humira Biosimilar Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Humira Biosimilar Producers in 2022
Table 20. World Humira Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Humira Biosimilar Company Evaluation Quadrant
Table 22. World Humira Biosimilar Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Humira Biosimilar Production Site of Key Manufacturer
Table 24. Humira Biosimilar Market: Company Product Type Footprint
Table 25. Humira Biosimilar Market: Company Product Application Footprint
Table 26. Humira Biosimilar Competitive Factors
Table 27. Humira Biosimilar New Entrant and Capacity Expansion Plans
Table 28. Humira Biosimilar Mergers & Acquisitions Activity
Table 29. United States VS China Humira Biosimilar Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Humira Biosimilar Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Humira Biosimilar Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Humira Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Humira Biosimilar Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Humira Biosimilar Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Humira Biosimilar Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Humira Biosimilar Production Market Share (2018-2023)
Table 37. China Based Humira Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Humira Biosimilar Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Humira Biosimilar Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Humira Biosimilar Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Humira Biosimilar Production Market Share (2018-2023)
Table 42. Rest of World Based Humira Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Humira Biosimilar Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Humira Biosimilar Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Humira Biosimilar Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Humira Biosimilar Production Market Share (2018-2023)
Table 47. World Humira Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Humira Biosimilar Production by Type (2018-2023) & (K Units)
Table 49. World Humira Biosimilar Production by Type (2024-2029) & (K Units)
Table 50. World Humira Biosimilar Production Value by Type (2018-2023) & (USD Million)
Table 51. World Humira Biosimilar Production Value by Type (2024-2029) & (USD Million)
Table 52. World Humira Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Humira Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Humira Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Humira Biosimilar Production by Application (2018-2023) & (K Units)
Table 56. World Humira Biosimilar Production by Application (2024-2029) & (K Units)
Table 57. World Humira Biosimilar Production Value by Application (2018-2023) & (USD Million)
Table 58. World Humira Biosimilar Production Value by Application (2024-2029) & (USD Million)
Table 59. World Humira Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Humira Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Cadila Healthcare Basic Information, Manufacturing Base and Competitors
Table 62. Cadila Healthcare Major Business
Table 63. Cadila Healthcare Humira Biosimilar Product and Services
Table 64. Cadila Healthcare Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Cadila Healthcare Recent Developments/Updates
Table 66. Cadila Healthcare Competitive Strengths & Weaknesses
Table 67. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Torrent Pharmaceuticals Major Business
Table 69. Torrent Pharmaceuticals Humira Biosimilar Product and Services
Table 70. Torrent Pharmaceuticals Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Torrent Pharmaceuticals Recent Developments/Updates
Table 72. Torrent Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Amgen Basic Information, Manufacturing Base and Competitors
Table 74. Amgen Major Business
Table 75. Amgen Humira Biosimilar Product and Services
Table 76. Amgen Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Amgen Recent Developments/Updates
Table 78. Amgen Competitive Strengths & Weaknesses
Table 79. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 80. Boehringer Ingelheim Major Business
Table 81. Boehringer Ingelheim Humira Biosimilar Product and Services
Table 82. Boehringer Ingelheim Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Boehringer Ingelheim Recent Developments/Updates
Table 84. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis Humira Biosimilar Product and Services
Table 88. Novartis Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Recent Developments/Updates
Table 90. Novartis Competitive Strengths & Weaknesses
Table 91. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 92. Samsung Bioepis Major Business
Table 93. Samsung Bioepis Humira Biosimilar Product and Services
Table 94. Samsung Bioepis Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Samsung Bioepis Recent Developments/Updates
Table 96. Samsung Bioepis Competitive Strengths & Weaknesses
Table 97. Viatris Basic Information, Manufacturing Base and Competitors
Table 98. Viatris Major Business
Table 99. Viatris Humira Biosimilar Product and Services
Table 100. Viatris Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Viatris Recent Developments/Updates
Table 102. Viatris Competitive Strengths & Weaknesses
Table 103. Pfizer Basic Information, Manufacturing Base and Competitors
Table 104. Pfizer Major Business
Table 105. Pfizer Humira Biosimilar Product and Services
Table 106. Pfizer Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Pfizer Recent Developments/Updates
Table 108. Pfizer Competitive Strengths & Weaknesses
Table 109. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 110. Fresenius Kabi Major Business
Table 111. Fresenius Kabi Humira Biosimilar Product and Services
Table 112. Fresenius Kabi Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Fresenius Kabi Recent Developments/Updates
Table 114. Coherus Basic Information, Manufacturing Base and Competitors
Table 115. Coherus Major Business
Table 116. Coherus Humira Biosimilar Product and Services
Table 117. Coherus Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Humira Biosimilar Upstream (Raw Materials)
Table 119. Humira Biosimilar Typical Customers
Table 120. Humira Biosimilar Typical Distributors
Table 1. World Humira Biosimilar Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Humira Biosimilar Production Value by Region (2018-2023) & (USD Million)
Table 3. World Humira Biosimilar Production Value by Region (2024-2029) & (USD Million)
Table 4. World Humira Biosimilar Production Value Market Share by Region (2018-2023)
Table 5. World Humira Biosimilar Production Value Market Share by Region (2024-2029)
Table 6. World Humira Biosimilar Production by Region (2018-2023) & (K Units)
Table 7. World Humira Biosimilar Production by Region (2024-2029) & (K Units)
Table 8. World Humira Biosimilar Production Market Share by Region (2018-2023)
Table 9. World Humira Biosimilar Production Market Share by Region (2024-2029)
Table 10. World Humira Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Humira Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Humira Biosimilar Major Market Trends
Table 13. World Humira Biosimilar Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Humira Biosimilar Consumption by Region (2018-2023) & (K Units)
Table 15. World Humira Biosimilar Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Humira Biosimilar Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Humira Biosimilar Producers in 2022
Table 18. World Humira Biosimilar Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Humira Biosimilar Producers in 2022
Table 20. World Humira Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Humira Biosimilar Company Evaluation Quadrant
Table 22. World Humira Biosimilar Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Humira Biosimilar Production Site of Key Manufacturer
Table 24. Humira Biosimilar Market: Company Product Type Footprint
Table 25. Humira Biosimilar Market: Company Product Application Footprint
Table 26. Humira Biosimilar Competitive Factors
Table 27. Humira Biosimilar New Entrant and Capacity Expansion Plans
Table 28. Humira Biosimilar Mergers & Acquisitions Activity
Table 29. United States VS China Humira Biosimilar Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Humira Biosimilar Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Humira Biosimilar Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Humira Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Humira Biosimilar Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Humira Biosimilar Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Humira Biosimilar Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Humira Biosimilar Production Market Share (2018-2023)
Table 37. China Based Humira Biosimilar Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Humira Biosimilar Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Humira Biosimilar Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Humira Biosimilar Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Humira Biosimilar Production Market Share (2018-2023)
Table 42. Rest of World Based Humira Biosimilar Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Humira Biosimilar Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Humira Biosimilar Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Humira Biosimilar Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Humira Biosimilar Production Market Share (2018-2023)
Table 47. World Humira Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Humira Biosimilar Production by Type (2018-2023) & (K Units)
Table 49. World Humira Biosimilar Production by Type (2024-2029) & (K Units)
Table 50. World Humira Biosimilar Production Value by Type (2018-2023) & (USD Million)
Table 51. World Humira Biosimilar Production Value by Type (2024-2029) & (USD Million)
Table 52. World Humira Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Humira Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Humira Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Humira Biosimilar Production by Application (2018-2023) & (K Units)
Table 56. World Humira Biosimilar Production by Application (2024-2029) & (K Units)
Table 57. World Humira Biosimilar Production Value by Application (2018-2023) & (USD Million)
Table 58. World Humira Biosimilar Production Value by Application (2024-2029) & (USD Million)
Table 59. World Humira Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Humira Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Cadila Healthcare Basic Information, Manufacturing Base and Competitors
Table 62. Cadila Healthcare Major Business
Table 63. Cadila Healthcare Humira Biosimilar Product and Services
Table 64. Cadila Healthcare Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Cadila Healthcare Recent Developments/Updates
Table 66. Cadila Healthcare Competitive Strengths & Weaknesses
Table 67. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 68. Torrent Pharmaceuticals Major Business
Table 69. Torrent Pharmaceuticals Humira Biosimilar Product and Services
Table 70. Torrent Pharmaceuticals Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Torrent Pharmaceuticals Recent Developments/Updates
Table 72. Torrent Pharmaceuticals Competitive Strengths & Weaknesses
Table 73. Amgen Basic Information, Manufacturing Base and Competitors
Table 74. Amgen Major Business
Table 75. Amgen Humira Biosimilar Product and Services
Table 76. Amgen Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Amgen Recent Developments/Updates
Table 78. Amgen Competitive Strengths & Weaknesses
Table 79. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 80. Boehringer Ingelheim Major Business
Table 81. Boehringer Ingelheim Humira Biosimilar Product and Services
Table 82. Boehringer Ingelheim Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Boehringer Ingelheim Recent Developments/Updates
Table 84. Boehringer Ingelheim Competitive Strengths & Weaknesses
Table 85. Novartis Basic Information, Manufacturing Base and Competitors
Table 86. Novartis Major Business
Table 87. Novartis Humira Biosimilar Product and Services
Table 88. Novartis Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Novartis Recent Developments/Updates
Table 90. Novartis Competitive Strengths & Weaknesses
Table 91. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 92. Samsung Bioepis Major Business
Table 93. Samsung Bioepis Humira Biosimilar Product and Services
Table 94. Samsung Bioepis Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Samsung Bioepis Recent Developments/Updates
Table 96. Samsung Bioepis Competitive Strengths & Weaknesses
Table 97. Viatris Basic Information, Manufacturing Base and Competitors
Table 98. Viatris Major Business
Table 99. Viatris Humira Biosimilar Product and Services
Table 100. Viatris Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Viatris Recent Developments/Updates
Table 102. Viatris Competitive Strengths & Weaknesses
Table 103. Pfizer Basic Information, Manufacturing Base and Competitors
Table 104. Pfizer Major Business
Table 105. Pfizer Humira Biosimilar Product and Services
Table 106. Pfizer Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Pfizer Recent Developments/Updates
Table 108. Pfizer Competitive Strengths & Weaknesses
Table 109. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 110. Fresenius Kabi Major Business
Table 111. Fresenius Kabi Humira Biosimilar Product and Services
Table 112. Fresenius Kabi Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Fresenius Kabi Recent Developments/Updates
Table 114. Coherus Basic Information, Manufacturing Base and Competitors
Table 115. Coherus Major Business
Table 116. Coherus Humira Biosimilar Product and Services
Table 117. Coherus Humira Biosimilar Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of Humira Biosimilar Upstream (Raw Materials)
Table 119. Humira Biosimilar Typical Customers
Table 120. Humira Biosimilar Typical Distributors
LIST OF FIGURES
Figure 1. Humira Biosimilar Picture
Figure 2. World Humira Biosimilar Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Humira Biosimilar Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Humira Biosimilar Production (2018-2029) & (K Units)
Figure 5. World Humira Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 6. World Humira Biosimilar Production Value Market Share by Region (2018-2029)
Figure 7. World Humira Biosimilar Production Market Share by Region (2018-2029)
Figure 8. North America Humira Biosimilar Production (2018-2029) & (K Units)
Figure 9. Europe Humira Biosimilar Production (2018-2029) & (K Units)
Figure 10. China Humira Biosimilar Production (2018-2029) & (K Units)
Figure 11. Japan Humira Biosimilar Production (2018-2029) & (K Units)
Figure 12. Humira Biosimilar Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 15. World Humira Biosimilar Consumption Market Share by Region (2018-2029)
Figure 16. United States Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 17. China Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 18. Europe Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 19. Japan Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 20. South Korea Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 22. India Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Humira Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Humira Biosimilar Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Humira Biosimilar Markets in 2022
Figure 26. United States VS China: Humira Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Humira Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Humira Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Humira Biosimilar Production Market Share 2022
Figure 30. China Based Manufacturers Humira Biosimilar Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Humira Biosimilar Production Market Share 2022
Figure 32. World Humira Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Humira Biosimilar Production Value Market Share by Type in 2022
Figure 34. Syringe
Figure 35. Pen
Figure 36. World Humira Biosimilar Production Market Share by Type (2018-2029)
Figure 37. World Humira Biosimilar Production Value Market Share by Type (2018-2029)
Figure 38. World Humira Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Humira Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Humira Biosimilar Production Value Market Share by Application in 2022
Figure 41. Ankylosing Spondylitis
Figure 42. Rheumatoid Arthritis
Figure 43. Crohn’s Disease
Figure 44. Other
Figure 45. World Humira Biosimilar Production Market Share by Application (2018-2029)
Figure 46. World Humira Biosimilar Production Value Market Share by Application (2018-2029)
Figure 47. World Humira Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Humira Biosimilar Industry Chain
Figure 49. Humira Biosimilar Procurement Model
Figure 50. Humira Biosimilar Sales Model
Figure 51. Humira Biosimilar Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
Figure 1. Humira Biosimilar Picture
Figure 2. World Humira Biosimilar Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Humira Biosimilar Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Humira Biosimilar Production (2018-2029) & (K Units)
Figure 5. World Humira Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 6. World Humira Biosimilar Production Value Market Share by Region (2018-2029)
Figure 7. World Humira Biosimilar Production Market Share by Region (2018-2029)
Figure 8. North America Humira Biosimilar Production (2018-2029) & (K Units)
Figure 9. Europe Humira Biosimilar Production (2018-2029) & (K Units)
Figure 10. China Humira Biosimilar Production (2018-2029) & (K Units)
Figure 11. Japan Humira Biosimilar Production (2018-2029) & (K Units)
Figure 12. Humira Biosimilar Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 15. World Humira Biosimilar Consumption Market Share by Region (2018-2029)
Figure 16. United States Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 17. China Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 18. Europe Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 19. Japan Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 20. South Korea Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 22. India Humira Biosimilar Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Humira Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Humira Biosimilar Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Humira Biosimilar Markets in 2022
Figure 26. United States VS China: Humira Biosimilar Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Humira Biosimilar Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Humira Biosimilar Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Humira Biosimilar Production Market Share 2022
Figure 30. China Based Manufacturers Humira Biosimilar Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Humira Biosimilar Production Market Share 2022
Figure 32. World Humira Biosimilar Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Humira Biosimilar Production Value Market Share by Type in 2022
Figure 34. Syringe
Figure 35. Pen
Figure 36. World Humira Biosimilar Production Market Share by Type (2018-2029)
Figure 37. World Humira Biosimilar Production Value Market Share by Type (2018-2029)
Figure 38. World Humira Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Humira Biosimilar Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Humira Biosimilar Production Value Market Share by Application in 2022
Figure 41. Ankylosing Spondylitis
Figure 42. Rheumatoid Arthritis
Figure 43. Crohn’s Disease
Figure 44. Other
Figure 45. World Humira Biosimilar Production Market Share by Application (2018-2029)
Figure 46. World Humira Biosimilar Production Value Market Share by Application (2018-2029)
Figure 47. World Humira Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Humira Biosimilar Industry Chain
Figure 49. Humira Biosimilar Procurement Model
Figure 50. Humira Biosimilar Sales Model
Figure 51. Humira Biosimilar Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
